Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Celator Pharmaceuticals
Exited company

Celator Pharmaceuticals Inc.

Details
Region
Atlantic
Industry sector
Medical/health
Investment year
2003
Fund
Diversified Portfolio
Learn More
About the company

Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies designed to target cancer cells. The company’s lead product is in clinical development for the treatment of acute myeloid leukemia.